Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: Scand J Gastroenterol. 2010 Nov 22;46(3):333–340. doi: 10.3109/00365521.2010.537679

Table III.

Hazard ratio for death among patients with gastric cancer.

Chemokine polymorphism No. of deaths Person-years Hazard ratio (95% CI)a Hazard ratio (95% CI)b
CCR2
   rs1799864 G>A
   GG 219 9812.4 1.0 1.0
   A carrier 43 1287.6 1.4 (1.0–1.9) 1.5 (1.1–2.1)
CCR5
   rs333 delta 32
      ++ 195 8766.9 1.0 1.0
      +− 65 2244.6 1.2 (0.9–1.6) 1.2 (0.9–1.6)
   rs2734648 G>T
      GG 126 3720.5 1.0 1.0
      T carrier 135 7378.6 0.7 (0.5–0.9) 0.8 (0.6–1.0)
   rs1799987 A>G
      AA 87 2922.5 1.0 1.0
      G carrier 167 8103.8 0.8 (0.6–1.0) 0.9 (0.7–1.2)
   rs1800024 C>T
      CC 210 9642.4 1.0 1.0
      T carrier 46 1374.5 1.4 (1.0–1.9) 1.5 (1.1–2.1)
CX3CR1
   rs3732379 G>A
      GG 125 5557.4 1.0 1.0
      A carrier 136 5539.2 1.1 (0.9–1.4) 1.2 (0.9–1.5)
   rs3732378 C>T
      CC 157 6575.7 1.0 1.0
      T carrier 101 4503.8 1.0 (0.8–1.3) 1.0 (0.8–1.3)
CXCL12
   rs1801157 G>A
      GG 173 6791.9 1.0 1.0
      A carrier 85 4290.4 0.9 (0.7–1.1) 1.0 (0.8–1.4)
a

Unadjusted.

b

Adjusted for age, sex, smoking status, education, and stage of disease.